News | News By Subject | News by Disease News By Date | Search News

Nausea News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
FDA Clears INSYS' Syndros     7/5/2016
Bay Area's Heron (HRTX) Surges as the FDA Finds No Deficiency with SUSTOL NDA, Starts Labeling Discussions     4/19/2016
Heron (HRTX)'s Sustol Finally Gets a Date with the FDA     3/3/2016
FDA Delays Decision of Bay Area-Based Heron (HRTX)'s Nausea Drug Sustol     1/15/2016
Midatech Bags Galena Biopharma  (GALE)'s Zuplenz in ~$29.75 Million Deal     12/18/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Eisai Inc. (ESALF.PK) Grabs FDA Approval For Chemotherapy Side Effect Drug AKYNZEO┬«     10/13/2014
Acacia Pharma Touts Positive Phase 3 Data For APD421     10/7/2014
Daiichi Sankyo, Inc. (4568.t) Wagers Up To $650 Million On Charleston Laboratories, Inc.'s Pain And Opioid-Induced Nausea And Vomiting Drug     8/7/2014
FDA Green Lights Eisai Inc. (ESALF.PK)'s ALOXI ®To Prevent Nausea And Vomiting Due To Chemotherapy In Kids     5/29/2014
Tesaro, Inc. (TSRO) Announces Successful Achievement Of Primary And All Secondary Endpoints In Third And Final Phase 3 Trial Of Rolapitant     5/13/2014
GlaxoSmithKline (GSK)'s High-Dose Zofran Pulled From Market     12/7/2012
Simcere Pharmaceutical Group Announces SFDA Approval to Manufacture and Market Palonosetron in China     8/12/2010
FDA Approves Strativa Pharmaceuticals' Zuplenz(R) (ondansetron) Oral Soluble Film     7/6/2010

News from Around the Web
ReliefBand Is A Wearable Device Aimed At Fighting Nausea Caused By Motion, Morning Sickness     1/11/2016
New VR Display Gentler On Brain; Reduces Nausea And Fatigue, Stanford University Study     8/10/2015
Nausea Drug May Treat Withdrawal From Addiction, Stanford University Study Shows     2/18/2009
Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary     10/2/2007
Acupuncture Does Not Reduce Radiotherapy-Induced Nausea, but Patients Believe It Does     9/26/2007
No Link Between Anti-Nausea Drug, Heart Trouble     9/24/2007
Delayed Nausea After Chemo Lowers Quality Of Life     10/30/2006
Chinese Medicine Kills One Child, Makes 151 Sick     6/21/2005
FDA: Use Caution When Prescribing Crestor     6/10/2004
ConjuChem     4/19/2004
Warning On Antidepressant Doses     3/11/2004
Pregnant & Nauseous? Try Ginger     1/12/2004

Press Releases
Axim Biotech Clinical Study To Develop Bioequivalent Product To Marinol Listed On Clinicaltrials.Gov     5/16/2017
Acacia Pharma Announces Positive Results From Its Fourth And Final Pivotal Trial Of BAREMSIS For The Rescue Treatment Of PONV     2/13/2017
Reliefband Technologies Unveils The Reliefband Neurowave - The Most Advanced Wearable For The Drug-Free Treatment Of Nausea     1/4/2017
Sea-Band Acupressure Wrist Bands Offer Proven Relief For Most Causes Of Nausea - Including Morning Sickness - And Are Recommended By JAMA     10/27/2016
Braeburn Pharma And Camurus Expand Collaboration And License Agreement To Include New Combination Product For Pain And Nausea     10/24/2016
Acacia Pharma Announces Positive Results From A Pivotal Phase 3 Trial Of BAREMSIS For The Treatment Of Post-Operative Nausea & Vomiting     8/12/2016
Heron (HRTX) Announces FDA Approval Of SUSTOL (Granisetron) Extended-Release Injection For The Prevention Of Chemotherapy-Induced Nausea And Vomiting     8/10/2016
Veritas Pharma Inc Reaches Important Scientific Milestone; Animal Studies Fully Underway To Evaluate The Safety And Effectiveness Of Cannabis Strains     8/10/2016
Helsinn Group Signs Exclusive Agreement With Purdue Pharma Canada For The Distribution And Licensing Rights Of Akynzeo (Netupitant/Palonosetron Combo) In Canada     4/25/2016
Acacia Pharma Initiates Second Pivotal Phase 3 Treatment Study With Baremsis (APD421) In Post-Operative Nausea & Vomiting (PONV)     3/21/2016
Specialised Therapeutics Australia Grants Sublicense For Anti-Emetic Products To Mundipharma For Australia And New Zealand     3/7/2016
FDA Approves Merck & Co. (MRK)'s Single-Dose EMEND (Fosaprepitant Dimeglumine) For Injection, In Combination With Other Antiemetic Agents, For The Prevention Of Delayed Nausea And Vomiting In Adults Receiving Moderately Emetogenic Chemotherapy (MEC)     2/4/2016
Acacia Pharma Announces Positive Results From Second Pivotal Phase 3 Study Of BAREMSIS (APD421) In Prevention Of Post-Operative Nausea & Vomiting     1/5/2016
Reliefband Scores $5 Million to Launch Anti-Nausea Wearable to Public     12/16/2015
Swissmedic Approves Akynzeo (netupitant/palonosetron) For Use In The Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In Switzerland     12/15/2015